Evaluation Study for the "Jockey Club E-Generation: Impact Extension Project for Chronic Knee Pain Management"
Launched by THE UNIVERSITY OF HONG KONG · Aug 21, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The "Jockey Club E-Generation: Impact Extension Project for Chronic Knee Pain Management" is a study aimed at helping older adults with long-term knee pain. The trial will look at how effective a new self-management program using tele-rehabilitation technology is in improving the quality of life for those suffering from knee discomfort. This study will involve about 858 participants from community centers in Hong Kong. To be eligible, participants must be at least 55 years old, live in the community, have reported knee pain in the last year, and be able to communicate in Cantonese or Mandarin. However, those with certain medical conditions, like recent strokes or severe knee injuries, won't be able to participate.
Participants in the study will be divided into two groups. One group will start the 12-week program right away, while the other group will wait for 12 weeks before beginning. Throughout the study, researchers will measure various outcomes, including pain levels, physical ability, and overall well-being. The hope is that those in the program will see greater improvements in their health and quality of life compared to those who wait. If you're interested in improving your knee pain and overall health, this study might be a good opportunity to consider.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • i. Aged ≥55 years;
- • ii. Community-dwelling;
- • iii. With self-reported knee pain problem currently or in the past 12 months;
- • iv. Cognitively sound (screened by the Clock Drawing Test (CDT) ≤ 4 (Agrell \& Dehlin, 1998));
- • v. Able to understand and communicate in Cantonese or Mandarin.
- Exclusion Criteria:
- • i. Diagnosed with stroke, myocardial infarction, injury or inflammation of the knee, autoimmune disease, unable to walk in the past three months;
- • ii. Users/ of Hospital Authority medical consultation or physiotherapy or occupational therapy services related to osteoarthritis knee;
- • iii. Screened to have three or above conditions including significant knee symptom score 5 or above, WOMAC Score ≥48, 5 times Sit to Stand test \>16.7 seconds, Time Up and Go Test \>14 seconds, Age \>80 and BMI \>25.
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Pui Hing Chau, PhD
Principal Investigator
School of Nursing, The University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported